These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 12082530

  • 1. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
    Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo MZ, Engles J, Yochem R, Ratovitski E, Sidransky D, Jen J.
    Oncogene; 2002 May 02; 21(19):3003-10. PubMed ID: 12082530
    [Abstract] [Full Text] [Related]

  • 2. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I.
    Cancer Res; 2005 Jun 01; 65(11):4485-9. PubMed ID: 15930262
    [Abstract] [Full Text] [Related]

  • 3. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.
    Chopra S, Fernandez De Mattos S, Lam EW, Mann DJ.
    J Biol Chem; 2002 Sep 06; 277(36):32413-6. PubMed ID: 12119282
    [Abstract] [Full Text] [Related]

  • 4. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.
    Clin Cancer Res; 2003 Nov 15; 9(15):5652-9. PubMed ID: 14654548
    [Abstract] [Full Text] [Related]

  • 5. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 6. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY.
    J Biol Chem; 2002 Jan 18; 277(3):2302-10. PubMed ID: 11704659
    [Abstract] [Full Text] [Related]

  • 7. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
    Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX, Grossman AB.
    J Clin Endocrinol Metab; 2002 Jun 18; 87(6):2635-43. PubMed ID: 12050228
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A, Niki T, Moriyama S, Funata N, Moriyama H, Nishimura Y, Tsuchida R, Kato JY, Fukayama M.
    Pathol Int; 2004 Sep 18; 54(9):675-81. PubMed ID: 15363035
    [Abstract] [Full Text] [Related]

  • 9. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.
    Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426
    [Abstract] [Full Text] [Related]

  • 10. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M.
    Clin Cancer Res; 2001 Dec 25; 7(12):4130-5. PubMed ID: 11751512
    [Abstract] [Full Text] [Related]

  • 11. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
    Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI.
    Nat Cell Biol; 2004 Dec 25; 6(12):1229-35. PubMed ID: 15531880
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S, Katayose Y, Yamamoto K, Mizuma M, Yabuuchi S, Oda A, Rikiyama T, Onogawa T, Yoshida H, Hayashi H, Ohtsuka H, Motoi F, Egawa S, Kato J, Unno M.
    Anticancer Res; 2009 Jun 25; 29(6):2015-24. PubMed ID: 19528460
    [Abstract] [Full Text] [Related]

  • 13. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
    Shintani S, Li C, Mihara M, Hino S, Nakashiro K, Hamakawa H.
    Oncology; 2003 Jun 25; 65(4):355-62. PubMed ID: 14707456
    [Abstract] [Full Text] [Related]

  • 14. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N.
    Blood; 2005 Jan 15; 105(2):775-83. PubMed ID: 15353483
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, Lai MD, Lei HY, Huang W.
    Mol Cancer Res; 2007 Oct 15; 5(10):1063-72. PubMed ID: 17951406
    [Abstract] [Full Text] [Related]

  • 16. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
    Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG.
    EMBO J; 2002 Jul 01; 21(13):3390-401. PubMed ID: 12093740
    [Abstract] [Full Text] [Related]

  • 17. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schäfer N, Höller TT, Fischer HP, Büttner R, Gütgemann I.
    Hum Pathol; 2007 Nov 01; 38(11):1621-7. PubMed ID: 17651785
    [Abstract] [Full Text] [Related]

  • 18. Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.
    Cong SY, Pepers BA, Zhou TT, Kerkdijk H, Roos RA, van Ommen GJ, Dorsman JC.
    Neurobiol Dis; 2012 Jun 01; 46(3):673-81. PubMed ID: 22426400
    [Abstract] [Full Text] [Related]

  • 19. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
    Tsuchida R, Miyauchi J, Shen L, Takagi M, Tsunematsu Y, Saeki M, Honna T, Yamada S, Teraoka H, Kato JY, Mizutani S.
    Jpn J Cancer Res; 2002 Sep 01; 93(9):1000-6. PubMed ID: 12359053
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y.
    Oncol Rep; 2004 Feb 01; 11(2):277-84. PubMed ID: 14719054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.